SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY

被引：0

作者：

Ashina, Messoud ^{[1
]}

Goadsby, Peter J. ^{[2
,3
]}

Reuter, Uwe ^{[4
]}

Silberstein, Stephen ^{[5
]}

Dodick, David W. ^{[6
]}

Xue, Fei ^{[7
]}

Zhang, Feng ^{[7
]}

Cheng, Sunfa ^{[7
]}

Chou, Denise E. ^{[7
]}

Lima, Gabriel Paiva da Silva ^{[7
]}

机构：

[1] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Dept Neurol,Danish Headache Ctr, Copenhagen, Denmark

[2] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA

[3] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England

[4] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[5] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA

[6] Mayo Clin, Dept Neurol, Scottsdale, AZ USA

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

CEPHALALGIA | 2020年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MTV20-DP-0

引用

页码：60 / 61

页数：2

共 50 条

[31] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY [J].

Banerji, A. ;

Hao, J. ;

Yu, M. ;

Bernstein, J. ;

Johnston, D. ;

Riedl, M. .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) :S21-S21

[32] A long-term open-label safety study of galcanezumab in Japanese patients with migraine [J].

Hirata, Koichi ;

Takeshima, Takao ;

Sakai, Fumihiko ;

Tatsuoka, Yoshihisa ;

Suzuki, Norihiro ;

Igarashi, Hisaka ;

Nakamura, Tomomi ;

Ozeki, Akichika ;

Yamazaki, Hiroyoshi ;

Skljarevski, Vladimir .

EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) :721-733

[33] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension [J].

Santos, Raul D. ;

Duell, P. Barton ;

East, Cara ;

Guyton, John R. ;

Moriarty, Patrick M. ;

Chin, Wai ;

Mittleman, Robert S. .

EUROPEAN HEART JOURNAL, 2015, 36 (09) :566-575

[34] Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension [J].

Deodhar, Atul ;

Navarro-Compan, Victoria ;

Poddubnyy, Denis ;

Gensler, Lianne S. ;

Ramiro, Sofia ;

Tomita, Tetsuya ;

Marzo-Ortega, Helena ;

Fleurinck, Carmen ;

Vaux, Thomas ;

Massow, Ute ;

de Peyrecave, Natasha ;

van der Heijde, Desiree ;

Baraliakos, Xenofon .

RMD OPEN, 2025, 11 (01)

[35] One-year sustained efficacy of erenumab in episodic migraine Results of the STRIVE study [J].

Goadsby, Peter J. ;

Reuter, Uwe ;

Hallstroem, Yngve ;

Broessner, Gregor ;

Bonner, Jo H. ;

Zhang, Feng ;

Wright, Ian K. ;

Chou, Denise E. ;

Klatt, Jan ;

Picard, Hernan ;

Lenz, Robert A. ;

Mikol, Daniel D. .

NEUROLOGY, 2020, 95 (05) :E469-E479

[36] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY [J].

Correll, C. ;

Goldman, R. ;

Tocco, M. ;

Pikalov, A. ;

Deng, L. ;

Loebel, A. ;

Coghill, D. .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 :105-105

[37] Long-term safety and efficacy of rotigotine in patients with idiopathic RLS: 5-year results front a prospective multinational open-label follow-up study [J].

Hogl, I. ;

Trenkwalder, C. ;

Garcia-Borreguero, D. ;

Kohnen, R. ;

Poewe, W. ;

Stiasny-Kolster, K. ;

Bauer, L. ;

Fichtner, A. ;

Schollmayer, E. ;

Oertel, W. .

MOVEMENT DISORDERS, 2010, 25 (07) :S517-S517

[38] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study [J].

Gevaert, Philippe ;

Saenz, Rebecca ;

Corren, Jonathan ;

Han, Joseph K. ;

Mullol, Joaquim ;

Lee, Stella E. ;

Ow, Randall A. ;

Zhao, Rui ;

Howard, Monet ;

Wong, Kit ;

Islam, Lutaf ;

Ligueros-Saylan, Monica ;

Omachi, Theodore A. ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) :957-+

[39] Long-term treatment with zonisamide: Results of a 2 year open-label extension study [J].

Wroe, S. ;

Duncan, R. .

EPILEPSIA, 2006, 47 :138-138

[40] LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY [J].

Fleischmann, R. ;

van Vollenhoven, R. ;

Vencovsky, J. ;

Alten, R. ;

Davies, O. ;

Stach, C. ;

de Longueville, M. ;

VanLunen, B. ;

Choy, E. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 :435-435

← 1 2 3 4 5 →